Bibo

Bibo is an Indian digital-first pharmaceutical brand that provides holistic healthcare solutions specifically targeting respiratory conditions with natural and Ayurvedic formulations. Founded in 2019 and headquartered in Bangalore, India, Hilt Brands India Private Limited operates under the brand name Bibo, focusing on respiratory health products. The company has undergone a Seed funding round led by AH Ventures, raising INR 8. 998 mn on June 3, 2022, with a total capital raised of INR 8.

998 mn. The founder, Vikash Kumar, has a history of entrepreneurial ventures, although details about previous companies are not specified. Bibo specializes in digital-first healthcare products aimed at respiratory conditions, offering a range of natural and Ayurvedic formulations. Key products include the Bibo Nasal Spray, made with a 100% natural formulation featuring Tulsi, and the Breathofy Syrup, which effectively addresses various cough types.

The company has built a loyal customer base of over 100,000 users in India, with aspirations to expand internationally. In the most recent fiscal year 2023, Bibo reported a revenue of INR 80,065. 1, with an EBITDA of INR -101,357. 5.

Bibo intends to leverage its recent Seed funding of INR 8. 998 mn to broaden its product line and enhance market penetration. The company is exploring new respiratory health products, with plans for a rollout in late 2023. Bibo also aims to expand beyond the Indian market, targeting international consumers seeking natural remedies for respiratory issues, with specific focus on regions in Southeast Asia by 2024.